September 2021 DMID Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

NB: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Fiscal Year (FY) 2023 Concepts

Diagnostics Preclinical Services Program

Request for Proposals—proposed FY 2023 initiative

For the published request for proposals, check the April 15, 2022 solicitation, Diagnostics Preclinical Services Program.

Biological and Emerging Infections Research Resources Program (BEI-RRP)

For the published request for proposals, check the December 23, 2021 solicitation, The Biological and Emerging Infections Research Resources Program (BEI-RRP).

Preclinical Services for Biopharmaceutical Product Development

For the published request for proposals, check the January 24, 2022 solicitation, Preclinical Services for Biopharmaceutical Product Development.

Partnerships for Rapid Diagnostics and Phenotypic Antibacterial Susceptibility Testing for Bacteremia or Hospital Acquired Pneumonia

For the published request for applications, check the February 23, 2022 Guide notice, Partnerships for Rapid Diagnostics and Phenotypic Antibacterial Susceptibility Testing for Bacteremia or Hospital Acquired Pneumonia (R01, Clinical Trial Not Allowed).

Improved Drug Susceptibility Testing (DST) for Tuberculosis

For the published request for applications, check the March 2, 2022 Guide announcement, Improved Drug Susceptibility Testing (DST) for Tuberculosis (R01, Clinical Trial Not Allowed).

Biocontainment Laboratory Support for Pandemic Preparedness

For the published request for applications, check the March 11, 2022 Guide announcement, Emergency Awards—Biocontainment Facility Improvements and Building System Upgrades To Support Pandemic Preparedness (G20, Clinical Trial Not Allowed).
 

Content last reviewed on